We have extensive experience in all aspects of life sciences finance, including institutional sales, capital markets, investment banking, investor and public relations, sell-side analysis, and buy-side analysis. We have an equally strong foundation in the life sciences (6 Ph.D.s on staff), which enables us to understand our clients’ R&D, regulatory, and commercial strategy. The combination of financial service and life science expertise allow us to best serve our clients’ needs.
Ashlee Bennett has extensive domain knowledge in pharmaceutical drug design, microbiology and immunotherapies, having over ten years of experience working in biomedical research. With expertise in both biotechnology and data science, Ashlee enjoys tackling analytical challenges using her experience as a research scientist, as well as quantitative computational tools and machine learning techniques. Fueled by intellectual curiosity, she has a passion for critical evaluation of new technologies and therapeutic strategies, and projection of their broader impact on the biotech and pharmaceutical industry landscape. Ashlee holds a Bachelors of Science degree from Drexel University, and received a M.A., M.Phil. and Ph.D. in Microbiology and Immunology from Columbia University.
Ryan Cinalli has over 10 years experience in basic and translational research, with expertise in regenerative medicine and cancer biology. Prior to joining the LifeSci team, Ryan was a National Science Foundation Fellow at NYU’s Skirball Institute for Biomolecular Medicine. His research career began at the University of Pennsylvania where he trained in cancer biology with Craig B. Thompson. Ryan’s research is published in several scientific journals, including Cell, Science and Nature. He holds a PhD in Cell Biology from NYU, and a BS in Biochemistry from Stockton College.
Patrick Dolezal has accumulated a broad skill set in the life sciences over the past seven years. He holds a Master of Science degree in Biology from New York University where he completed his thesis in a translational research laboratory focused on Alzheimer’s disease. Patrick is an avid SCUBA diver and performed epidemiological research for the Divers Alert Network while based in Cozumel, Mexico.
Adam Evertts has expertise in molecular biology and has been focused in the life sciences for the last seven years. He spent two years as a Postbaccalaureate Fellow at the National Institutes of Health and completed his Ph.D. at Princeton in the Department of Molecular Biology. While at Princeton, Adam led efforts to encourage scientists to consider careers outside of academia and presented his efforts to the Princeton Board of Trustees.
Managing Director, Senior Analyst
Jerry Isaacson has broad experience in biotechnology, having worked in both public and private biotech companies in areas ranging from medicinal chemistry and analytical chemistry to patents and investor/public relations. Jerry has also worked as a Research Analyst for the Medical Technology Stock Letter. He brings a passion for science to his work and combines that with a deep interest in and knowledge of the biotech industry to constantly get at the important, underlying scientific questions that drive company valuations. Jerry holds a Bachelor of Arts degree in Chemistry from Harvard University and received his Ph.D. in Organic Chemistry from the University of California in San Diego.
David Sherman has studied neuroscience for over nine years with broad exposure to translational research and cutting-edge technology. He has a deep understanding of biological systems that allows him to draw subtle distinctions between research programs and effectively evaluate market potential. David has a Bachelor of Arts degree in Biology from Harvard University, where he conducted a research project on motor control and Parkinson’s Disease for his senior thesis. He completed a Ph.D. at UCLA in the Department of Neurobiology studying the neural control of breathing.
Sam Slutsky has more than 3 years of experience in healthcare research. Prior to joining the LifeSci team, Sam conducted orthopedic research under Dr. Javad Parvizi at the Rothman Institute in Philadelphia. His work was presented at the American Association of Hip and Knee Surgeons (AAHKS) 24th annual meeting. Sam holds a Bachelor of Arts in Economics from the University of Rochester. He was a member of the school’s NCAA baseball team, where he compiled several accolades including all-conference and academic all-district.